Form 4: Jennifer L. Good Executes Stock Options and Sells Shares of Rhythm Pharmaceuticals
SEC Form 4 Filing
Director Jennifer L. Good exercised stock options and sold shares of Rhythm Pharmaceuticals (RYTM) on August 26, 2024, according to a Form 4 filing with the SEC.
Summary
- On August 26, 2024, Jennifer L. Good, a director of Rhythm Pharmaceuticals, exercised stock options to acquire shares of common stock at prices of $22.93, $21.37, $18.99, and $4.15.
- She acquired 2,100 shares at $22.93, 4,945 shares at $21.37, 5,763 shares at $18.99, and 1,700 shares at $4.15.
- Following these transactions, she sold 3,000 shares at a weighted average price of $50.0087, with individual sales ranging from $50.00 to $50.045.
- After these transactions, Ms. Good directly owns 14,508 shares of Rhythm Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of insider trading activity. The transactions themselves don't inherently indicate positive or negative sentiment about the company's future.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily indicate a broader trend within the pharmaceutical industry.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the effect is likely minimal given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| May 22, 2024 | Date of adoption of Rule 10b5-1 trading plan. |
| August 26, 2024 | Date of stock option exercises and stock sales. |
| August 28, 2024 | Date of Form 4 signature. |
| June 18, 2029 | Expiration date of one of the stock options. |
| June 16, 2030 | Expiration date of one of the stock options. |
| June 08, 2031 | Expiration date of one of the stock options. |
| June 07, 2032 | Expiration date of one of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.